Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

<< Previous

Bullboard Posts

Next >>

Comment by 2021Gambleon Apr 01, 2024 9:31am

83 Views

Post# 35962544

RE:RE:RE:RE:New Press Release - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

Well, I certainly hope they have products in the pipeline ... I mean really....

but until they're approved, they are only in the pipeline - so yes, under development ok, that's all good and fine - but unless I really misunderstood things, the other 7 haven't received approval yet, just in the pipeline